Alzheimer's disease-like pattern of 18F-FDG uptake during a hyperglycemic state and negative 11C-PiB binding in a patient with mild cognitive impairment

Journal of Alzheimer's Disease

Volumn 42, Issue 2, 2014, Pages 385-389

  Ishibashi, Kenji ^a,b   Miura, Yoshiharu ^b   Oda, Keiichi ^a   Ishiwata, Kiichi ^a   Ishii, Kenji ^a  

^a TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

^b TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

Author keywords

11C PiB; 18F FDG; hyperglycemia; PET

Indexed keywords

AMYLOID BETA PROTEIN; FLUORODEOXYGLUCOSE F 18; GLUCOSE; PITTSBURGH COMPOUND B; BENZOTHIAZOLE DERIVATIVE; N-METHYL-2-(4'-METHYLAMINOPHENYL)-6-HYDROXYBENZOTHIAZOLE;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CEREBELLUM CORTEX; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG UPTAKE; FRONTAL LOBE; GLUCOSE BLOOD LEVEL; GLUCOSE UTILIZATION; HUMAN; HYPERGLYCEMIA; MALE; MILD COGNITIVE IMPAIRMENT; POSITRON EMISSION TOMOGRAPHY; POSTERIOR CINGULATE; PRECUNEUS; COMPLICATION; DIAGNOSTIC USE; FEMALE; MIDDLE AGED; SCINTISCANNING; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BENZOTHIAZOLES; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; HYPERGLYCEMIA; MALE; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; POSITRON-EMISSION TOMOGRAPHY;

EID: 84916883776     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-140639     Document Type: Article

References (21)

1. Magistretti PJ, PellerinL(1996) Cellular bases of brain energy metabolism and their relevance to functional brain imaging: Evidence for a prominent role of astrocytes. Cereb Cortex 6, 50-61.
2. Pellerin L, Magistretti PJ (1994) Glutamate uptake into astrocytes stimulates aerobic glycolysis: A mechanism coupling neuronal activity to glucose utilization. Proc Natl Acad Sci U S A 91, 10625-10629.
3. Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, Iwatsubo T, Jack CR, Jr., Kaye J, Montine TJ, Park DC, Reiman EM, Rowe CC, Siemers E, Stern Y, Yaffe K, Carrillo MC, Thies B, Morrison-Bogorad M,WagsterMV, Phelps CH (2011) Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7, 280-292.
4. Kawasaki K, Ishii K, Saito Y, Oda K, Kimura Y, Ishiwata K (2008) Influence of mild hyperglycemia on cerebral FDG distribution patterns calculated by statistical parametric mapping. Ann Nucl Med 22, 191-200.
5. Burns CM, Chen K, Kaszniak AW, Lee W, Alexander GE, Bandy D, Fleisher AS, Caselli RJ, Reiman EM (2013) Higher serum glucose levels are associated with cerebral hypometabolism in Alzheimer regions. Neurology 80, 1557-1564.
6. Klunk WE, Engler H, Nordberg A, Wang Y, Blomqvist G, Holt DP, Bergstrom M, Savitcheva I, Huang GF, Estrada S, Ausen B, Debnath ML, Barletta J, Price JC, Sandell J, Lopresti BJ, Wall A, Koivisto P, Antoni G, Mathis CA, Langstrom B (2004) Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Ann Neurol 55, 306-319.
7. Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, Gamst A, Holtzman DM, Jagust WJ, Petersen RC, Snyder PJ, Carrillo MC, Thies B, Phelps CH (2011) The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7, 270-279.
8. Ishibashi K, Ishii K, Oda K, Mizusawa H, Ishiwata K (2010) Competition between 11C-raclopride and endogenous dopamine in Parkinson's disease. Nucl Med Commun 31, 159-166.
9. Wang GJ, Volkow ND, Overall J, Hitzemann RJ, Pappas N, Pascani K, Fowler JS (1996) Reproducibility of regional brain metabolic responses to lorazepam. J Nucl Med 37, 1609-1613.
10. Wahl RL, Henry CA, Ethier SP (1992) Serum glucose: Effects on tumor and normal tissue accumulation of 2-[F-18]-fluoro- 2-deoxy-D-glucose in rodents with mammary carcinoma. Radiology 183, 643-647.
11. Hara T, Higashi T, Nakamoto Y, Suga T, Saga T, Ishimori T, Ishizu K, Kawashima H, Kawase S, Matsumoto K, Togashi K (2009) Significance of chronic marked hyperglycemia on FDG-PET: Is it really problematic for clinical oncologic imaging? Ann Nucl Med 23, 657-669.
12. Yamada K, Endo S, Fukuda H, Abe Y, Yoshioka S, Itoh M, Kubota K, Hatazawa J, Satoh T, Matsuzawa T, et al. (1985) Experimental studies on myocardial glucose metabolism of rats with 18F-2-fluoro-2-deoxy-D-glucose. Eur J Nucl Med 10, 341-345.
13. Anticevic A, Cole MW, Murray JD, Corlett PR, Wang XJ, Krystal JH (2012) The role of default network deactivation in cognition and disease. Trends Cogn Sci 16, 584-592.
14. Sperling RA, Laviolette PS,O'Keefe K, O'Brien J, RentzDM, Pihlajamaki M, Marshall G, HymanBT, Selkoe DJ, Hedden T, Buckner RL, Becker JA, Johnson KA (2009) Amyloid deposition is associated with impaired default network function in older persons without dementia. Neuron 63, 178-188.
15. Baker LD, Cross DJ, Minoshima S, Belongia D, Watson GS, Craft S (2011) Insulin resistance and Alzheimer-like reductions in regional cerebral glucose metabolism for cognitively normal adults with prediabetes or early type 2 diabetes. Arch Neurol 68, 51-57.
16. Craft S (2007) Insulin resistance and Alzheimer's disease pathogenesis: Potential mechanisms and implications for treatment. Curr Alzheimer Res 4, 147-152.
17. Musen G, Jacobson AM, Bolo NR, Simonson DC, Shenton ME, McCartney RL, Flores VL, Hoogenboom WS (2012) Resting-state brain functional connectivity is altered in type 2 diabetes. Diabetes 61, 2375-2379.
18. Craft S (2009) The role of metabolic disorders in Alzheimer disease and vascular dementia: Two roads converged. Arch Neurol 66, 300-305.
19. Grillo CA, Piroli GG, Hendry RM, Reagan LP (2009) Insulinstimulated translocation of GLUT4 to the plasma membrane in rat hippocampus is PI3-kinase dependent. Brain Res 1296, 35-45.
20. Lucignani G, Namba H, Nehlig A, Porrino LJ, Kennedy C, Sokoloff L (1987) Effects of insulin on local cerebral glucose utilization in the rat. J Cereb Blood Flow Metab 7, 309-314.
21. American-Diabetes-Association (2005) Diagnosis and classification of diabetes mellitus. Diabetes Care 28(Suppl 1), S37-S42.